ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,014Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 1448

$477K Total Retail Price of All Prescriptions

Rank: 150 out of 1448

816 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,124 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CARVEDILOL 782 703 1 1
LISINOPRIL 669 618 2 5
SIMVASTATIN 602 544 3 3
METOPROLOL SUCCINATE 565 512 4 6
WARFARIN SODIUM 483 443 5 8
ISOSORBIDE MONONITRATE ER 443 384 6 16
CLOPIDOGREL 424 381 7 10
FUROSEMIDE 330 306 8 7
ATORVASTATIN CALCIUM 326 292 9 4
METOPROLOL TARTRATE 326 302 9 9
PLAVIX 259 221 11 14
CRESTOR 215 183 12 17
SOTALOL 208 199 13 40
POTASSIUM CHLORIDE 208 204 13 19
ATENOLOL 186 186 15 12
AMIODARONE HCL 177 159 16 22
AMLODIPINE BESYLATE 147 143 17 2
DIGOXIN 130 128 18 13
FLECAINIDE ACETATE 123 110 19 53
PRAVASTATIN SODIUM 114 114 20 20
NITROSTAT 101 79 21 31
LOSARTAN POTASSIUM 98 98 22 11
FENOFIBRATE 94 86 23 54
NITROGLYCERIN PATCH 90 83 24 98
MULTAQ 89 85 25 57
TRILIPIX 80 68 26 86
PRADAXA 78 73 27 27
HYDROCHLOROTHIAZIDE 75 67 28 18
KLOR-CON M20 71 71 29 161
LOVASTATIN 65 30 30 35
LIPITOR 58 49 31 30
DIOVAN 52 52 32 15
ZETIA 50 38 33 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.